New report shows slight increase in U.S., E.U. philanthropic funding for AIDS

"Private philanthropists in the European Union and the U.S. spent some $644 million on global HIV/AIDS programs in 2011, a five percent increase from 2010, largely driven by funding from a small number of large donors, a new report [.pdf] has revealed," IRIN reports. "In their annual report, two groups -- the U.S.-based Funders Concerned About AIDS (FCAA) and the European HIV/AIDS Funders Group (EFG) -- reported that U.S. funders spent $491 million in 2011 while E.U. funders spent $170 million," the news service writes (11/9). The report notes in a footnote that "$17.4 million was deducted from the combined total to avoid double-counting of grants that were given between U.S. and European-based funders and re-granted in 2011" (November 2012).

"Although the amount of money donated by private funders grew, the growth could be attributed to a few large donors; several other donors had, in fact, reduced their funding," IRIN adds (11/9). "While this overall increase was driven by increased funding from the Bill & Melinda Gates Foundation (which represented half of all U.S.-based AIDS philanthropy), and by the majority of E.U.-based funders, decreases by the majority of U.S.-based funders largely neutralized overall growth in AIDS-related philanthropy in 2011," according to a UNAIDS press release, which notes, "Analysis also reveals that few new funders are entering the field of AIDS philanthropy" (11/8). "The report's authors note that 2012 funding is forecasted to remain level," IRIN writes, adding, "Experts are calling for greater funding, not only from the private funders but also from western governments and beneficiary nations" (11/9).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide reduced mortality in obese patients by lowering infection-related deaths during COVID-19 pandemic